Most Shared

LGBT characters swept the Emmys this year. Here's why it's not enough.

'LGBT characters deserve to be more than the co-stars in straight people’s lives. We must be the protagonists too.'

LGBT characters swept the Emmys this year. Here's why it's not enough.

As a writer, my dream has always been to create a world of characters that reflect my life as a gay man of color.

My world of friends ranges in age, ethnicity, and sexual orientation, and I know I’m not the only one with this sort of broad social tapestry. Then why is it that I rarely see a world like mine on TV or film?

So, I did something. Last year, I wrote and directed a short film called "I Can't With You."


The cast of "I Can't with You." Photo by the author, used with permission.

It’s the story of Charlie and Annie, two lifelong friends who are drifting apart. I wanted to tell a story that addressed relationships between old friends who have endured the natural internal and external shifts we all go through as people. I wanted to make something that specifically showcased a relationship between a gay man and a straight woman, as I feel like it’s one we haven’t seen much of in popular media as of late, and I love the dynamic.

We live in a time with more LGBT representation in television than ever before.

This year's Emmy's were more diverse than ever. (Film, you better catch up now.) Yet, even with some major TV shows having prominent LGBT characters, we still don’t have many shows exploring the gay experience in a thorough, thought-provoking, and entertaining way.

"The Real O’Neals" has a fun, heartfelt gay coming-of-age story at its core. "Transparent" is pure magic in how it explores the underrepresented trans community. "Orange Is the New Black" is brilliant and offers up some unique, complicated LGBT characters in the sea of its vast ensemble. And other shows, from "Modern Family" to "Empire" to "Master of None," have interesting gay characters contributing to their narratives as well.

Aziz Ansari and Alan Yang, writers for "Master of None," accept a 2016 Emmy award. Photo by Chris Pizzello/Invision/AP.

However, most of these shows do not let the LGBT characters to anchor the narrative. Why? Are we really only allowed three or four shows? Where are all the LGBT lead characters with complex, diverse lives?

To be fair, the lack of major gay representation in today's media doesn’t stem from a lack of trying.

"Looking" was an interesting, complex show. However, it got a lot of flak from gay audiences because it was the only show out there with a gay male leading character, and not all gay men felt like it was telling their story. And once upon a time, we actually had more diversity in shows like "Queer as Folk," "The L Word," and "Noah’s Arc," but their time has since passed.

The web is doing a much better job in offering up gay protagonist stories with a variety of tones and characters too, but their budgets are small and their platforms are even smaller: "EastSiders," "The Outs," "Where the Bears Are," and "The Gay and Wondrous Life of Caleb Gallo" all come to mind.

Industry decision makers must take greater chances on gay representation in the media.

Are major networks and streaming platforms afraid that mainstream audiences won’t be able to handle a story told primarily through the gay lens? I don’t think so. And, mind you, when I say mainstream audiences, I mean straight and white audiences, who have proven over and over again that they (mostly) also love diversity.

Even so, the majority of stories being offered are still told through a straight, white lens. I love some of these stories — "Terms of Endearment," "The Devil Wears Prada," "Who’s Afraid of Virginia Woolf," and "The Shining" are all movies that give me life.

Who doesn't love "The Devil Wears Prada"? Photo via 20th Century Fox.

But I’m ready to see a more real depiction of life as I know it. I want a more colorful, queer world on my TV.

This is what I know: We must press on to create a world where a young gay person, whether white or of color, can see themselves as the hero.

Growing up, I rarely got to watch anything where I actually saw myself in the hero. Instead, people like me were usually the flamboyant villain, the shameful oddball, or the servant. Eventually, I graduated to the sassy best friend or co-worker.  The whole Latino thing is also worth its own rant, but in all seriousness, we haven’t shifted far enough away from this dilemma.

LGBT characters deserve to be more than the co-stars in straight people’s lives. We must be the protagonists too.

The cast and writers of "Orange Is the New Black." Photo via Dimitrios Kambouris/Getty Images.

We do a lot more than just come out or go to prison or help our friends through their problems. We have rich, vast lives, and we must challenge ourselves to deliver LGBT content that will appeal to all audiences. And the more opportunities we are given to be the heroes, the greater chance we have of acceptance and empathy in the real world.

We need gay comedies. We need trans dramas. We need lesbian-driven mysteries.

All of these voices matter and should contribute to the media landscape.

Now is the time to take these chances. Now is the time to be bold. I want my Gay TV. And you may not know it yet, but you do too. Try seeing life through the lens of a gay man of color. Or an older trans woman. Or a bi college student. We are all made better by trying to see the world through all kinds of eyes. And, hell, you may even like what you see.

via Kat Stickler / TikTok

Kat Stickler has created a hilarious series of videos about her husband that a lot of women say they can relate to because theirs behave the exact same way.

Stickler is a mother who shares funny videos about her domestic life on TikTok where she's earned over six million followers.

In the videos, she transforms into her husband Mike by throwing on a backward baseball cap and adopting a deeper voice. From the videos, it's pretty clear that Mike always wants some sort of praise for doing the things he's supposed to do.

The interesting thing about the couple is that they went from dating to parents pretty much overnight. Three months after their first date, Kat was pregnant and they were married.

Keep Reading Show less
via Kat Stickler / TikTok

Kat Stickler has created a hilarious series of videos about her husband that a lot of women say they can relate to because theirs behave the exact same way.

Stickler is a mother who shares funny videos about her domestic life on TikTok where she's earned over six million followers.

In the videos, she transforms into her husband Mike by throwing on a backward baseball cap and adopting a deeper voice. From the videos, it's pretty clear that Mike always wants some sort of praise for doing the things he's supposed to do.

The interesting thing about the couple is that they went from dating to parents pretty much overnight. Three months after their first date, Kat was pregnant and they were married.

Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer — most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving — and for longer — than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval — an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases — something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."